Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.

@article{Wang2014PostmarketingSO,
  title={Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.},
  author={Yali Wang and Duo Dong and Gang Cheng and Shuyan Zuo and Dawei Liu and Xiaoxi Du},
  journal={Vaccine},
  year={2014},
  volume={32 44},
  pages={
          5875-9
        }
}
Japanese encephalitis (JE) is the most severe form of viral encephalitis in Asia and no specific treatment is available. Vaccination provides an effective intervention to prevent JE. In this paper, surveillance data for adverse events following immunization (AEFI) related to SA-14-14-2 live-attenuated Japanese encephalitis vaccine (Chengdu Institute of Biological Products) was presented. This information has been routinely generated by the Chinese national surveillance system for the period… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Similar Papers

Loading similar papers…